Takayuki Nakano

Takayuki Nakano

Auto-generated profile, based on publicly available information

Takayuki Nakano

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2003 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MNMakiya Nishikawa
Makiya Nishikawa
TNTakayuki Nakano
Takayuki Nakano
TOTakayuki Okabe
Takayuki Okabe
NHNobuko Hamaguchi
Nobuko Hamaguchi
YYYasuomi Yamasaki
Yasuomi Yamasaki
MHMitsuru Hashida
Mitsuru Hashida

16 March 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
KSKazuki Suruga
Kazuki Suruga
KSKazuyoshi Suenari
Kazuyoshi Suenari
TNTakayuki Nakano
Takayuki Nakano
HTHajime Takemoto
Hajime Takemoto
YHYuu Hashimoto
Yuu Hashimoto
HIHiroshi Ito
Hiroshi Ito

9 September 2023 in The American Journal of Cardiology
Verified
Journal Article
Closed access
TNTakayuki Nakano
Takayuki Nakano
HIHiroki Ikenaga
Hiroki Ikenaga
ATAtsushi Takeda
Atsushi Takeda
YMYuichi Morita
Yuichi Morita
THTasuku Higashihara
Tasuku Higashihara
YNYukiko Nakano
Yukiko Nakano

1 April 2022 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
TNTakayuki Nakano
Takayuki Nakano
KSKazuyoshi Suenari
Kazuyoshi Suenari
AOAkira Okada
Akira Okada
YHYohei Hyodo
Yohei Hyodo
STShunsuke Tomomori
Shunsuke Tomomori
YNYukiko Nakano
Yukiko Nakano

18 August 2025 in JACC: Asia
Verified
Journal Article
Open access
MSMikio Shigehara
Mikio Shigehara
HIHiroki Ikenaga
Hiroki Ikenaga
AKAtsushi Kuraishi
Atsushi Kuraishi
AOAyano Osawa
Ayano Osawa
MTMakoto Takeuchi
Makoto Takeuchi
YNYukiko Nakano
Yukiko Nakano
The pulmonary artery pulsatility index (PAPi) is a hemodynamic index that reflects right ventricular function. However, the association between PAPi and prognosis in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) remains unclear. This study aimed to determine how periprocedural changes in the PAPi are associated with patients' prognosis after TAVR. Of the 405 consecutive patients who underwent TAVR for severe aortic stenosis at Hiroshima University Hospital, those with available periprocedural right heart catheter data were included in this study. Patients were divided into 2 groups with a cutoff PAPi value of 3.11 post-TAVR determined by the receiver-operating characteristic curve for the primary endpoint. The primary endpoint was the composite of all-cause mortality and hospitalization caused by heart failure. The secondary endpoint was all-cause mortality. Additionally, factors in the nonimproved PAPi group were investigated. This study enrolled 238 patients. The median follow-up was 405.5 days (Q1-Q3: 353-861 days). A lower PAPi was associated with an increased risk of the primary endpoint (23.3% vs 9.9%; log-rank P < 0.001). After multivariate Cox proportional hazard analysis, post-TAVR PAPi >3.11 was still predictive factor for the primary endpoint (HR: 3.04; 95% CI: 1.30-7.13; P = 0.011). Furthermore, the secondary endpoint was significantly increased in lower PAPi group (log-rank P = 0.010). A nonimproved PAPi predictor was pre-TAVR aortic valve mean pressure gradient in multivariate analysis (OR: 1.02; 95% CI: 1.01-1.04; P = 0.003). The post-TAVR PAPi was associated with all-cause mortality and heart failure hospitalization.

29 November 2025 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
TNTakayuki Nakano
Takayuki Nakano
HIHiroki Ikenaga
Hiroki Ikenaga
KHKen-Ichi Hirano
Ken-Ichi Hirano
MSMikio Shigehara
Mikio Shigehara
AOAyano Osawa
Ayano Osawa
YNYukiko Nakano
Yukiko Nakano
Triglyceride-deposit cardiomyovasculopathy (TGCV) is characterized by diffuse narrowing of the coronary arteries because of triglyceride-deposit atherosclerosis. However, the plaque characteristics and prognosis of TGCV in patients with diffuse coronary artery disease remain unclear. This study aimed to describe the morphology of coronary arteries in TGCV using integrated backscatter intravascular ultrasound (IB-IVUS) and assess the effects on clinical outcomes. This single-center, retrospective observational study compared the IB-IVUS findings and clinical outcomes of patients with native coronary lesions of TGCV with those of patients with non-TGCV, all of whom had diffuse coronary artery disease. TGCV was diagnosed as (1) a low washout rate of iodine-123-β-methyl iodophenyl-pentadecanoic acid (BMIPP; <10%) on BMIPP single-photon emission computed tomography and (2) diffuse narrowing of the coronary arteries on coronary angiography. Thirty-one patients with diffuse coronary artery disease who underwent percutaneous coronary intervention were enrolled. Among these patients 10 (32%) were diagnosed with TGCV. IB-IVUS revealed that TGCV lesions had a significantly smaller ratio of the lipid area than non-TGCV lesions (20% ± 0.8% vs 23% ± 0.5%, p = 0.02). Conversely, the ratio of the calcification area tended to be larger. The Kaplan–Meier analysis revealed a significant increase in the rates of major adverse cardiovascular events in the TGCV group ( p = 0.01). Patients with diffuse coronary artery disease present TGCV characterized by a smaller ratio of the lipid area. TGCV might be associated with worse clinical outcomes. The study findings may contribute to its early diagnosis and management.